https://www.selleckchem.com/pr....oducts/alkbh5-inhibi
The 1-stage revision ($41,176; 95% CI, 23,361-58,991), DAIR with liner exchange ($41,267; 95% CI, 29,923-52,612) and DAIR ($46,605; 95% CI, 15,277-76,844) were associated with fewer costs at 12 months. Age 65 years and chronic complications of diabetes and hypertension were associated with increased costs in subgroup and regression analysis. Medical costs are highest at 12 months and for 2-stage revisions in hip and knee complex SSI cases. Further work should explore surgical outcomes correlated with costs to enhance pati
Like
Comment
Share
